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Background
Immunoglobulin levels are known to be elevated in HIV
infected children. However, little is known about the
effect of maternal HIV infection and the maternal altered
immune system on immunoglobulin levels in uninfected
children. As few data are available on immunoglobulins
from young healthy children, we used data from unin-
fected children born to hepatitis C virus (HCV) infected
women as a comparison.
Methods
Prospective data on immunoglobulin levels were availa-
ble from birth to 5 years for children enrolled in the Euro-
pean Collaborative Study (ECS) of children born to HIV-
1 infected women and from birth to 24 months for chil-
dren enrolled in the European Paediatric HCV Network
(EPHN). Children born to HIV/HCV co-infected women
were excluded. Smoothers (running means) illustrated
patterns of immunoglobulins over age by infection status.
Associations between infant and maternal factors and
child log10 total IgG, IgM and IgA levels were quantified in
linear regression analyses allowing for repeated measures
within child. Further analyses were performed using only
data of HIV exposed uninfected children to investigate
associations between child immunoglobulins and mater-
nal immunological and virological factors and anti-retro-
viral therapy exposure.
Results
1751 HIV uninfected, 190 HIV infected children (ECS),
173 HCV uninfected and 30 HCV infected children
(EPHN) were included. HIV infected children had higher
levels of all immunoglobulins compared to uninfected
children over all ages. HIV uninfected children had signif-
icantly higher IgG, IgM and IgA levels than HCV unin-
fected children upto at least 24 months, adjusting for
gender, prematurity and race. Prematurity was associated
with significantly lower levels of immunoglobulins upto
24 months. Children born to African women had higher
IgG and IgA levels upto 24 months than those born to
white women but lower IgM in the first 6 months.
Among HIV uninfected children higher IgG levels were
associated with elevated maternal IgG levels, as well for
measurements from 18 months to 5 years of age. No sig-
nificant effect of maternal CD4 count was observed. ART
exposure was associated with significantly lower IgG lev-
els at 6-24 months. Race was not associated with immu-
noglobulin levels in multivariable analyses in this sub-
group.
Conclusions
These findings indicate significant alterations in immu-
noglobulin levels in uninfected children born to HIV
infected women. This suggests that exposure to an acti-
vated maternal immune system is associated with an
altered humoral response in children without antigen
stimulation, and warrants further research.
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